Analyst consensus rating
Takeda Pharmaceutical Analyst Rating: Strong Buy
TAK is rated Strong Buy by 3 analysts with a $22.48 target. As of 2026-09-03.
Direct answer
Takeda Pharmaceutical's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $22.48.
Forecast evidence checked September 3, 2026.
Get free Takeda Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $18.56
- Average price target
- $22.48
- High price target
- $23.56
- Low price target
- $21.46
- Low target gap
- +15.6%
- Target upside
- +21.1%
- High target gap
- +27%
- Target range width
- 11.3%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- September 3, 2026
- Valid through
- September 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Takeda Pharmaceutical?
Takeda Pharmaceutical has a verified Strong Buy consensus. The same dataset has an average price target of $22.48.
How far are Takeda Pharmaceutical's low and high targets from the recorded price?
The low target implies +15.6%, while the high target implies +27%.
How many analysts are included in Takeda Pharmaceutical's consensus?
The verified consensus includes 3 analysts.
How is Takeda Pharmaceutical's target upside or downside calculated?
The average target of $22.48 is divided by the recorded price of $18.56, then one is subtracted to produce +21.1%. This does not guarantee a future return.
When was Takeda Pharmaceutical's analyst forecast verified?
The data was verified on 2026-09-03. The dataset is valid through 2026-09-10.